Personal profile
Biography
A/Prof Phillip Parente trained at Monash University graduating with First Class Honours in 1993. He completed training in Medical Oncology 2001 and completed a two-year Fellowship in Immunology and Melanoma at Ludwig Institute for Cancer Research at Austin Health. Initially, he worked as a Medical Oncologist at both Eastern Health and Austin Health. His current role is the Director of Cancer Services Eastern Health.
His main areas of interest are genitourinary cancers, lung cancers, and melanoma and he is considered a clinical lead in these areas of oncology. With respect to oncology research, he is principal investigator of numerous trials in his areas of interest. This has translated to numerous publications and presentations at local and international oncological conferences.
A/Prof Parente has professional interest in teaching and training. He is a senior member of the National Examining Panel for the Royal Australasian College of Physicians and past chair Advanced Trainee Committee Medical Oncology for the Royal Australasian College of Physicians. He is also the current Treasurer and Executive Committee Member of the Medical Oncology Group of Australia, (MOGA).
A/Prof Phillip Parente has completed a Master of Health and Medical Law in 2020 and is currently completing a Master of Human Rights Law at the Faculty of Law, The University of Melbourne.
Clinical activities
- Acting Director of Medical Oncology, Box Hill
- Medical Oncologist
- Specialist Advisory Committee Member - Medical Oncology, Royal College of Physicians, Lead in Assessment
Research interests
- Melanoma
- Lung cancer
- Urological cancers
Supervision interests
- Director of Undergraduate Third Year Teaching, Box Hill Hospital
Research area keywords
- melanoma
- lung cancer
- urological cancers
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Collaborations and top research areas from the last five years
-
Redefining genotyping in metastatic prostate cancer: a liquid biopsy strategy for equitable access
Kwan, E. (Primary Chief Investigator (PCI)), Herbison, H. (Associate Investigator (AI)), Pook, D. (Associate Investigator (AI)), Anton, A. (Associate Investigator (AI)), Tran, B. (Associate Investigator (AI)), Inderjeeth, A. J. (Associate Investigator (AI)), Beck, S. (Associate Investigator (AI)), George, A. (Associate Investigator (AI)), Chan, S. (Associate Investigator (AI)), Miranzadeh, S. (Associate Investigator (AI)), Taylor, R. (Associate Investigator (AI)), Lawrence, M. (Associate Investigator (AI)), Parente, P. (Associate Investigator (AI)) & Davis, I. (Associate Investigator (AI))
1/01/26 → 1/11/27
Project: Research
-
Melanoma Research Victoria (MRV) Collaboration
Mar, V. (Primary Chief Investigator (PCI)), McArthur, G. (Partner Investigator (PI)), Kee, D. (Partner Investigator (PI)), Underhill, C. (Partner Investigator (PI)), Vico-Alonso, C. (Chief Investigator (CI)), Ge, Z. (Chief Investigator (CI)), Yu, Z. (Chief Investigator (CI)), Button-Sloan, A. E. (Associate Investigator (AI)), Shackleton, M. (Associate Investigator (AI)), Trapani, J. A. (Associate Investigator (AI)), Fox, S. B. (Associate Investigator (AI)), Sandhu, S. (Associate Investigator (AI)), Dobrovic, A. (Associate Investigator (AI)), Neeson, P. J. (Associate Investigator (AI)), Gyorki, D. (Associate Investigator (AI)), Haydon, A. (Chief Investigator (CI)), Papenfuss , T. (Associate Investigator (AI)), Behren, A. (Associate Investigator (AI)), Hicks, R. J. (Associate Investigator (AI)), Parente, P. (Associate Investigator (AI)), Sheppard, K. E. (Associate Investigator (AI)), Underhill, C. (Associate Investigator (AI)), Harvey, K. (Associate Investigator (AI)), Speakman, D. (Associate Investigator (AI)), Kok, D. (Associate Investigator (AI)), Kelly, J. (Associate Investigator (AI)), Cebon , J. (Associate Investigator (AI)), Rao, A. (Associate Investigator (AI)) & Da Gama Duarte, J. (Associate Investigator (AI))
28/03/24 → 28/03/29
Project: Research
-
BMS-734016 - CA184104: Randomised, Multicentre, Double-blind, Phase 3 Trial comparing the efficacy of Ipilimumab in addition to Paclitaxel and Carboplatin versus placebo in addition
Parente, P. (Primary Chief Investigator (PCI))
1/11/14 → 31/12/15
Project: Research
-
A Phase 2 randomised double blind study comparing tremelimumab to placebo in second or third treatment of subjects with unresectable pleural or peritonela malignant mesothelioma
Parente, P. (Primary Chief Investigator (PCI))
1/08/13 → 31/08/14
Project: Research
-
A phase 3, randomised double blind study of Nivolumab Monaotherapy or Nivolumab combined with Ipilimumab versus Ipilimumab monotherapy in subjects with previously untreated unresectable or metastatic
Parente, P. (Primary Chief Investigator (PCI))
20/06/13 → 15/10/14
Project: Research
-
The association between health-related quality of life scores and clinical outcomes for people living with lung cancer: an Australian registry cohort study using patient-reported outcomes to drive value-based healthcare
Harden, S. V., King, M. T., Li, J. J., Tissera, S., Lloyd, M., Briggs, L., Wood, T., Billah, B., Samankula, D., Smith, S., Brand, M., Lang, T., Parente, P., McGrath, S., Langton, D., Dumnall, T., Jennings, B., Nicholls, S., Stirling, R. G. & Richardson, G. & 1 others, , Feb 2026, In: Thoracic Cancer. 17, 4, 16 p., e70245.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Metastatic testicular seminoma presenting as acute lower limb ischaemia
Chui, W., Gurrala, S., Hosking, P., Wong, P., Parente, P. & Sengupta, S., Jul 2024, In: Urology Case Reports. 55, 3 p., 102768.Research output: Contribution to journal › Article › Other › peer-review
Open Access -
Stage-Specific Guideline Concordant Treatment Impacts on Survival in Nonsmall Cell Lung Cancer: A Novel Quality Indicator
Tissera, S., Billah, B., Brand, M., Karim, M. N., Antippa, P., Blum, R., Caldecott, M., Conron, M., Faisal, W., Harden, S., Olesen, I., Parente, P., Richardson, G., Samuel, E., See, K., Underhill, C., Wright, G., Zalcberg, J. & Stirling, R. G., Dec 2024, In: Clinical Lung Cancer. 25, 8, p. e466-e478 13 p.Research output: Contribution to journal › Article › Research › peer-review
7 Link opens in a new tab Citations (Scopus) -
Patterns of care for people with small cell lung cancer in Victoria, 2011–19: a retrospective, population-based registry data study
Huang, J., Faisal, W., Brand, M., Smith, S., Alexander, M., Briggs, L., Conron, M., Duffy, M., John, T., Langton, D., Lesage, J., MacManus, M., Mitchell, P., Olesen, I., Parente, P., Philip, J., Samuel, E., Torres, J., Underhill, C. R. & Zalcberg, J. R. & 2 others, , Aug 2023, In: The Medical Journal of Australia. 219, 3, p. 120-126 7 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access6 Link opens in a new tab Citations (Scopus) -
Prostate-specific membrane antigen positron emission tomography-computed tomography use prior to systemic therapy in metastatic castration-resistant prostate cancer
Kelly, R., Jensen, A., Karunaratna, N., Wong, S., Shapiro, J., Weickhardt, A., Parente, P., Azad, A. A., Uccellini, A., Torres, J., Parnis, F., Goh, J., Kwan, E. M., Brown, S., Steer, C., Warren, M., Gibbs, P., Tran, B. & Anton, A., Feb 2023, In: BJU International. 131, 2, p. 179-182 4 p.Research output: Contribution to journal › Letter › Research › peer-review
1 Link opens in a new tab Citation (Scopus)